Related Experiment Videos

[Clinical studies of cefditoren pivoxil in pediatric field]

T Nishimura1, K Tabuki, S Aoki

  • 1Department of Pediatrics, Osaka Medical College.

Insights

Clinical studies show cefditoren pivoxil (CDTR-PI) granules are effective for pediatric bacterial infections. The antibiotic demonstrated excellent or good results in most cases with no significant side effects observed.

Area of Science:

  • Pediatric infectious diseases
  • Antibiotic therapy
  • Clinical pharmacology

Context:

  • Bacterial infections are a common concern in pediatric populations.
  • Cefditoren pivoxil (CDTR-PI) is a third-generation oral cephalosporin antibiotic.
  • Granule formulations offer advantages in pediatric medication adherence.

Purpose:

  • To evaluate the clinical efficacy and safety of cefditoren pivoxil (CDTR-PI) in pediatric patients with bacterial infections.
  • To assess treatment outcomes across various pediatric bacterial infections including tonsillitis, pneumonia, scarlet fever, impetigo, subcutaneous abscess, and urinary tract infections.

Summary:

  • A clinical study involved 14 pediatric patients diagnosed with bacterial infections.
  • Patients received cefditoren pivoxil (CDTR-PI) in a granule formulation.
  • Treatment yielded excellent outcomes in 12 cases, good in 1, and poor in 1, with no significant adverse drug events reported.

Impact:

  • Cefditoren pivoxil (CDTR-PI) granules represent a potentially effective and well-tolerated treatment option for pediatric bacterial infections.
  • The findings support the use of CDTR-PI in managing common childhood bacterial illnesses.
  • Further research may explore broader applications and long-term efficacy in pediatric populations.

Related Concept Videos